Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fine

Showing results (631-640 of 690) with videos related to

Pageof 69
Sort By:
Biorxiv : the Preprint Server for Biology|March 4, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Molecular Cell|March 27, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Oncogene|October 19, 2021
Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1Han Yan, Chih-Chieh Yu, Stuart A Fine, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2021
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fateTyler M Lu, Sean Houghton, Tarig Magdeldin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Common variation in genes related to innate immunity and risk of adult gliomaPreetha Rajaraman, Alina V Brenner, Mary Ann Butler, et al.
Kidney International|April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in CanadaS W Murphy, R N Foley, B J Barrett, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Plos One|December 14, 2012
Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilizationChibawanye I Ene, Lincoln Edwards, Gregory Riddick, et al.
Kidney International|June 9, 2000
Comparative hospitalization of hemodialysis and peritoneal dialysis patients in CanadaS W Murphy, R N Foley, B J Barrett, et al.
Pageof 69

Showing results (631-640 of 690) with videos related to

Sort By:
Pageof 69
Biorxiv : the Preprint Server for Biology|March 4, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Molecular Cell|March 27, 2025
Three-dimensional regulatory hubs support oncogenic programs in glioblastomaSarah L Breves, Dafne Campigli Di Giammartino, James Nicholson, et al.
Oncogene|October 19, 2021
Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1Han Yan, Chih-Chieh Yu, Stuart A Fine, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2021
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fateTyler M Lu, Sean Houghton, Tarig Magdeldin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Common variation in genes related to innate immunity and risk of adult gliomaPreetha Rajaraman, Alina V Brenner, Mary Ann Butler, et al.
Kidney International|April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in CanadaS W Murphy, R N Foley, B J Barrett, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
Plos One|December 14, 2012
Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilizationChibawanye I Ene, Lincoln Edwards, Gregory Riddick, et al.
Kidney International|June 9, 2000
Comparative hospitalization of hemodialysis and peritoneal dialysis patients in CanadaS W Murphy, R N Foley, B J Barrett, et al.
Pageof 69